Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

Adamis (ADMP) Submits Tempol IND for COVID-19, Shares Soar

Analyst Blog

Adamis (ADMP) submits an investigational new drug (IND) to the FDA for the investigational use of Tempol for the treatment of COVID-19.

REGNNegative Net Change GILDNegative Net Change LLYNegative Net Change ADMPNegative Net Change

Zacks Equity Research

Nordstrom (JWN) Benefits from Spike in Demand: Will It Sustain?

Analyst Blog

Despite COVID-related soft store traffic and weak EBIT margins, strength in the online business, led by robust customer demand and a stringent cost-saving plan, bodes well for Nordstrom (JWN).

ANFPositive Net Change JWNPositive Net Change TPRPositive Net Change CPRIPositive Net Change

Zacks Equity Research

Bristol Myers' (BMY) Opdivo Label Expansion Gets Priority Review

Analyst Blog

Bristol Myers' (BMY) sBLA for the label expansion of Opdivo for gastric cancer, gastroesophageal junction cancer or esophageal adenocarcinoma gets priority review.

ALKSNegative Net Change RHHBYNegative Net Change MRKNegative Net Change BMYNegative Net Change

Zacks Equity Research

Westamerica (WABC) Q4 Earnings Meet Estimates

Tale of the Tape

Westamerica (WABC) delivered earnings and revenue surprises of 0.00% and 10.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

WABCNegative Net Change

Zacks Equity Research

Union Pacific (UNP) Q4 Earnings Surpass Estimates, Rise Y/Y

Analyst Blog

Union Pacific's (UNP) freight revenues decline merely 1% in Q4. Moreover, overall volumes improve 3%.

UNPNegative Net Change KSUNegative Net Change NSCNegative Net Change CPNegative Net Change

Zacks Equity Research

Novo Nordisk (NVO) Files for Ozempic's Label Expansion in US

Analyst Blog

Novo Nordisk (NVO) submits a label expansion application to the FDA for the existing marketing authorization for Ozempic to include a new dose of 2.0 mg.

ALKSNegative Net Change

Zacks Equity Research

Why is it Advisable to Hold on to Cigna (CI) Stock Now?

Analyst Blog

Cigna (CI) looks poised to grow on the back of business rejig, which involves growing its healthcare business while lowering debt.

HUMPositive Net Change CINegative Net Change CNCPositive Net Change ANTMPositive Net Change

Zacks Equity Research

Western Union (WU) Expands in South Korea Via NH I&S Services

Analyst Blog

Western Union (WU) integrates its services with those of NH Investment & Securities in an effort to boost its presence in South Korea.

WMTNegative Net Change WUNegative Net Change MGINegative Net Change SQNegative Net Change

Zacks Equity Research

Perion (PERI) Announces Encouraging Preliminary Q4 Results

Analyst Blog

Perion Network (PERI) posts upbeat fourth-quarter and 2020 preliminary financial results, on the back of strength in the advertising business and synergies from recent acquisitions.

MUNegative Net Change PKINegative Net Change PERINegative Net Change SQNegative Net Change

Zacks Equity Research

Everbridge (EVBG) Introduces Enhanced Public Warning Platform

Analyst Blog

Everbridge (EVBG) enhances population alerting with the newly launched Public Warning Center, which enables public authorities to generate public alerts with multi-channel front-end interface.

GSNegative Net Change DDDPositive Net Change MRCYNegative Net Change EVBGPositive Net Change

Zacks Equity Research

Foot Locker (FL) Shines: Omni-Channel Efforts Boost Growth

Analyst Blog

Foot Locker's (FL) omni-channel initiatives, including digital strength and Power Store concept, appear encouraging. Also, it looks to expand assortments via meaningful partnerships.

NKENegative Net Change FLPositive Net Change BOOTNegative Net Change

Zacks Equity Research

Will Segmental Performance Aid Lockheed's (LMT) Q4 Earnings?

Analyst Blog

Lockheed Martin's (LMT) Q4 results are expected to have benefited from the delivery of its 123rd F-35A CTOL variant aircraft to the Italian Air Force.

LMTNegative Net Change LDOSNegative Net Change AJRDNegative Net Change RTXNegative Net Change

Zacks Equity Research

Kimberly-Clark (KMB) to Report Q4 Earnings: What's in the Offing?

Analyst Blog

Kimberly-Clark's (KMB) fourth-quarter 2020 results are likely to reflect gains from pandemic-induced demand, while softness in the K-C Professional unit is a concern.

KMBNo Net Change NWLNegative Net Change ELPositive Net Change MNSTNegative Net Change

Zacks Equity Research

ProPetro (PUMP) Provides Fourth-Quarter Preliminary Update

Analyst Blog

ProPetro's (PUMP) 2020 capital expenditures are projected to be lower than $85 million and meet the company's prior expectations.

CNXNegative Net Change PAGPNegative Net Change PUMPNegative Net Change DCPNegative Net Change

Zacks Equity Research

Ahead of AMD's Q4 Earnings: EPYC & Semi-Custom Products in Focus

Analyst Blog

Advanced Micro Devices' (AMD) Q4 performance is expected to have benefited from strength in EPYC processors and momentum in Semi-Custom domain owing to launch of gaming consoles.

MSFTPositive Net Change AMZNPositive Net Change AMDPositive Net Change GOOGLPositive Net Change

Zacks Equity Research

Hartford Financial (HIG) Launches Plan for Mental Health

Analyst Blog

Hartford Financial (HIG) introduces a plan to ease the financial stress of people suffering mental health illnesses.

HIGNegative Net Change AIGNegative Net Change METNegative Net Change ORINegative Net Change

Zacks Equity Research

Baker Hughes (BKR) Q4 Earnings Lag, Oil Demand to Recover in 2021

Analyst Blog

Despite energy market volatility, Baker Hughes (BKR) generates a positive free cash flow of $250 million in the fourth quarter.

SUNegative Net Change AMRCPositive Net Change BKRNegative Net Change WHDNegative Net Change

Zacks Equity Research

Murphy USA (MUSA) Provides Fourth-Quarter Preliminary Update

Analyst Blog

Murphy USA (MUSA) opens 15 new stores and re-launches 20 raze-and-rebuild stores in Q4.

CNXNegative Net Change MUSANegative Net Change PAGPNegative Net Change DCPNegative Net Change

Zacks Equity Research

Will Sarepta's (SRPT) Overdependence on Exondys 51 Hurt?

Analyst Blog

Sarepta Therapeutics' (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on Exondys 51 for near-term growth is a concern.

PFENegative Net Change MRNAPositive Net Change LLYNegative Net Change SRPTNegative Net Change

Zacks Equity Research

Mastercard (MA) Welcomes Paymentology to Its Fintech Platform

Analyst Blog

Mastercard (MA) will be working closely with Paymentology in a bid to support the latter in innovating new solutions and add scalability to its business.

AXPNegative Net Change MANegative Net Change VNegative Net Change DFSNegative Net Change

Zacks Equity Research

Alliant Energy's (LNT) Clean Energy & CAPEX Goals Bode Well

Analyst Blog

While Alliant Energy (LNT) is likely to benefit from its capital investments, focus on reducing emissions and a diverse customer mix, intensifying competition continues to be a woe.

XELNegative Net Change DTENegative Net Change DUKNegative Net Change LNTNegative Net Change

Zacks Equity Research

Northern Trust's (NTRS) Q4 Earnings Miss, Expenses Flare Up

Analyst Blog

Northern Trust's (NTRS) Q4 results reflect higher fee income and credit provision, partly muted by fall in net interest income and escalating expenses.

BKNegative Net Change NTRSPositive Net Change STTNegative Net Change FRCNegative Net Change

Zacks Equity Research

M&T Bank (MTB) Q4 Earnings Beat Estimates on High Fee Income

Analyst Blog

M&T Bank's (MTB) Q4 results reflect higher revenues, partly offset by escalating provisions and expenses.

MTBNegative Net Change BKNegative Net Change STTNegative Net Change FRCNegative Net Change

Zacks Equity Research

Merck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod

Analyst Blog

Merck (MRK)/Bayer's (BAYRY) vericiguat gets FDA approval for symptomatic chronic heart failure and reduced ejection fraction

MRKNegative Net Change NVSNegative Net Change AMGNNegative Net Change BAYRYNegative Net Change

Zacks Equity Research

Discover Financial (DFS) Q4 Earnings Surpass, Improve Y/Y

Analyst Blog

Discover Financial's (DFS) fourth-quarter earnings gain from a strong performance by its Direct Banking segment.

MCONegative Net Change DFSNegative Net Change SYFNegative Net Change ATHNegative Net Change

Zacks Equity Research

Cognizant (CTSH) to Buy Custom Software Developer Magenic

Analyst Blog

Cognizant's (CTSH) acquisition of Magenic Technologies is expected to boost its software product engineering footprint.

MSFTPositive Net Change CTSHNegative Net Change AMZNPositive Net Change WDAYPositive Net Change

Aniruddha Ganguly

4 Stocks to Watch on Rising Demand for Scientific Instruments

Industry Outlook

The Zacks Instruments - Scientific industry is gaining from strong life science, pharmaceutical and academic end-market demand. Industry participants MTD, WAT, PKI, and BRKR are set to gain from rising healthcare spending and exposure to developing economies like China and India.

MTDNegative Net Change PKINegative Net Change WATNegative Net Change BRKRNegative Net Change

Zacks Equity Research

Company News for Jan 21, 2021

Corporate Summary

Companies In The News Are: BK, TSN, GEVO, FULT.

BKNegative Net Change TSNNegative Net Change FULTNegative Net Change GEVOPositive Net Change

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for January 21st

Zacks #1 Rank Additions

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st.

TGTPositive Net Change FIVEPositive Net Change CROXNegative Net Change ARCBNegative Net Change

Zacks Equity Research

eXp World Holdings, Aramark, ABM Industries, Aptiv and ManpowerGroup highlighted as Zacks Bull and Bear of the Day

Press Releases

eXp World Holdings, Aramark, ABM Industries, Aptiv and ManpowerGroup highlighted as Zacks Bull and Bear of the Day

MANPositive Net Change ABMNegative Net Change ARMKNegative Net Change APTVNegative Net Change EXPIPositive Net Change